Source: Eur Respir J, 55 (3) 1901947; 10.1183/13993003.01947-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hana Serajeddini, Rachel L. Eddy, Christopher Licskai, David G. McCormack, Grace Parraga. FEV₁ and MRI ventilation defect reversibility in asthma and COPD. Eur Respir J, 55 (3) 1901947; 10.1183/13993003.01947-2019

Member's Comments

No comment yet.

Related content which might interest you: Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 The reversibility of bronchial obstruction and hyperinflation at COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Changes in FEV1 after recovery from COPD exacerbation are driven by heterogeneous regional changes in airway caliber and hyperinflation Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015 FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 Is residual volume reversibility a better marker than FEV1 reversibility in diagnosing reversible airway disease  in asthma? Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1 Source: Eur Respir J 2009; 33: 1396-1402 Year: 2009 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 The importance of lung hyperinflation during exacerbations of COPD Source: ISSN=ISSN 1810-6838, ISBN=, page=356 Year: 2006 The use of forced oscillation technique (FOT) in assessment of airway obstruction and airtrapping in elderly COPD patients Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 The improvement in pulmonary hyperinflation and air-flow limitation during tidal breathing by pulmonary rehabilitation in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 19s Year: 2002 FOT and hyperinflation in COPD Source: Annual Congress 2007 - Lung function II Year: 2007 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Lung volume dependence of airway geometry in a severe COPD patient with static hyperinflation Source: Eur Respir J 2006; 28: Suppl. 50, 509s Year: 2006 FEV1 is not sufficient for assessing bronchodilator reversibility in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 121s Year: 2004 The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation Source: Annual Congress 2007 - New drugs for asthma Year: 2007 The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Source: Eur Respir J 2003; 21: 95-10 Year: 2003 Forced inspiratory volume in one second (FIV1) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002 The effect of tiotropium on exacerbations and airflow in patients with COPD Source: Eur Respir J 2006; 27: 547-555 Year: 2006